Under the Federal Food, Drug, and Cosmetic Act (FDCA), selling unapproved peptides for human consumption can violate statutes prohibiting the introduction of misbranded or adulterated drugs into interstate commerce (21 U.S.C
Compounded GLP-1s have not been evaluated by the FDA, but side effects are expected to be similar to other GLP-1-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
The L-carnitine in the product comes from two sources: L-carnitine L-tartrate and acetyl-L-carnitine
The development of the DPP-4 inhibition concept for glucose-lowering therapy in type 2 diabetes originated on the fundament of the incretin concept
Never self-medicate without checking with your Physician
What Is KPV